Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04118374 · ClinicalTrials.gov registry record · NA
A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04118374 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 14 participants.
The verdict
NCT04118374, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The investigators will test the hypothesis that reducing insulin doses using a low carbohydrate diet (LCD) will be associated with with improved insulin sensitivity (Aim 1) and blood vessel health (Aim 2).
Interventions
- OTHER Standard Carb Diet
- OTHER Low Carb Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2021-11-24 |
| Est. Completion | 2024-06-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04118374
The ClinicalTrials.gov registry entry for NCT04118374 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Carb Diet is the first listed.
NCT04118374 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04118374 about?
NCT04118374 is a clinical study titled "A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes". The investigators will test the hypothesis that reducing insulin doses using a low carbohydrate diet (LCD) will be associated with with improved insulin sensitivity (Aim 1) and blood vessel health (Aim 2).
What is the current status of trial NCT04118374?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2021-11-24. Estimated completion is 2024-06-21.
What interventions are being tested in trial NCT04118374?
The interventions under investigation include: Standard Carb Diet (OTHER), Low Carb Diet (OTHER).
Who is sponsoring clinical trial NCT04118374?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.